Clinical Medical

Reviews and Case ReportsISSN: 2378-3656


 Open Access DOI:10.23937/2378-3656/1410391

A Case of Parkinsonism and Encephalopathy with Combined Lithium-Risperidone Therapy: Treatment with Pramipexole

Enes Tarık İnci and Tahir Kurtuluş Yoldaş

Article Type: Case Report | First Published: April 30, 2022

Lithium is a drug that has been used in the treatment of bipolar disorder for many years. Due to its narrow therapeutic range, systemic side effects can be seen frequently. Serious side effects can occur even in non-toxic doses. We present a case of parkinsonism and encephalopathy developed in a patient with normal lithium blood level who used lithium and risperidone combination therapy for bipolar disease. Lithium is a drug that has been used to treat bipolar disorder for over 60 years. Due to ...

 Open Access DOI:10.23937/2378-3656/1410390

Risk of Pulmonary Toxicity and Benefits of Bleomycin Containing Regimen in Early-Stage Hodgkin’s Lymphoma - A Case Report and Insights from Literature Review

Adebola Adetiloye, Farhana Alladin, Kuldeep Ghosh, Julio Valencia-Manrique, Rasha Alaameri, Ana Maria Victoria, John Cosico and Andrea Popescu-Martinez

Article Type: Case Report | First Published: April 30, 2022

Bleomycin is chemotherapeutic agent that has been used for cancer treatment for several years. However, potentially life-threatening lung toxicity is a major concern limiting its use. This is a case of a 64-year-old male presenting sub acutely with gradual onset of exertional shortness of breath and cough after completing 4 cycles of ABVD regimen for Stage 2b Hodgkin’s lymphoma. CT scan showed extensive bibasilar reticular opacities with honey combing suggestive of pulmonary fibrosis with Usua...

 Open Access DOI:10.23937/2378-3656/1410389

Prolonged Recovery of Neuromuscular Transmission during General Anaesthesia after Mivacurium Administration - Case Report

Paweł Radkowski, PhD, Katarzyna Podhorodecka and Mariusz Kęska

Article Type: Case Report | First Published: April 29, 2022

Mivacurium is the shortest-acting nondepolarizing relaxant, used for brief procedures, such as those performed in the ambulatory setting. The recommended intubating dose of 0.2 mg/kg usually provides a clinically effective neuromuscular block for approximately 15 to 20 minutes and spontaneous recovery is 95% complete within about 25 to 30 minutes. 71-years-old woman was admitted for an elective laparotomy surgery with an intraoperative examination. Standard monitoring and TOF Scan (both the addu...

Volume 9
Issue 4